Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University · NCT00349830
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 1
- Study start
- January 2002
- Record last updated
- February 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.
Being studied: blood draw
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma); Neoplasms
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- Age > or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
- Prior diagnosis of cancer or suspected of having cancer
- Karnofsky performance status of greater than 70
- Standard pretreatment evaluation
- Signed Stanford University Human Subjects Committee consent
Recruiting US locations
Stanford University School of Medicine
Stanford, CA 94305
Site contact: Rene Bonilla · 650-498-7703 · rbonilla@stanford.edu
Study contacts (from the official record)
- gitrialeligibility@stanford.edu gitrialeligibility@stanford.edu · 650-498-7757 · gitrialeligibility@stanford.edu
- gitrialeligibility@stanford.edu · 650-498-7757 · gitrialeligibility@stanford.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55